Liposome |
|
|
Niosomes |
|
Inefficient drug loading
Aggregation
Physical instability
|
Inorganic nanoparticles |
|
Possible toxicity
Low clearance
|
Dendrimer |
|
Inefficient drug loading
Possible toxicity
|
Nanosuspension |
|
|
Cyclodextrin complexes |
Chemical stability
High aqueous solubility
|
May cause irritation
Safety concern
|
Nanocrystals |
Tunable particle size
Sustained release of drug
Improved dose proportionality
Applicability to all administration routes
|
|
Nanodiamonds |
Chemical stability
Small size
Large surface area
High absorption capacity
|
|